Open Access. Powered by Scholars. Published by Universities.®
Biomedical Engineering and Bioengineering Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- CHO (19)
- Metabolic Engineering (19)
- Perfusion (18)
- Materials Genome (13)
- Product quality (11)
-
- CHO cells (9)
- Continuous (9)
- Scale-down (8)
- Glycosylation (7)
- Posters (7)
- Scale-up (7)
- Transcriptomics (7)
- Chromatography (6)
- Fed-batch (6)
- Metabolism (6)
- Monoclonal antibody (6)
- Product Quality (6)
- Productivity (6)
- Antibody (5)
- Integrated (5)
- Bioprocess (4)
- Bioprocess Development in Early Stages (4)
- Bioreactor (4)
- Cell culture (4)
- Fluid Dynamics in Medicine (4)
- Metabolomics (4)
- Perfusion culture (4)
- Process development (4)
- QbD (4)
- Bioreactors (3)
- Publication Year
- Publication
-
- Cell Culture Engineering XV (246)
- Integrated Continuous Biomanufacturing II (85)
- Vaccine Technology IV (48)
- Vaccine Technology III (35)
- Light Activated Tissue Regeneration and Therapy (21)
-
- Vaccine Technology II (21)
- Metabolic Engineering IX (20)
- Harnessing The Materials Genome: Accelerated Materials Development via Computational and Experimental Tools (16)
- Advancing Manufacture of Cell and Gene Therapies VI [2019] (8)
- Computational Fluid Dynamics (CFD) in Medicine And Biology in Conjunction With the Seventh International Biofluid Mechanics Symposium (5)
- Biological and Pharmaceutical Complex Fluids III: Protein Self-Assembly, Rheology and Interfacial Properties (4)
- Advances in Optics for Biotechnology, Medicine and Surgery XVI [2019] (1)
- File Type
Articles 391 - 420 of 510
Full-Text Articles in Biomedical Engineering and Bioengineering
Suspension Vero Cells (Svero) For Poliovirus Production: Effect Of Culture Passage On Growth Kinetics And Productivity, Guillermina Forno
Suspension Vero Cells (Svero) For Poliovirus Production: Effect Of Culture Passage On Growth Kinetics And Productivity, Guillermina Forno
Vaccine Technology IV
No abstract provided.
Systematically Characterizing Adventitious Agent Tests For Biologics, Rebecca Sheets
Systematically Characterizing Adventitious Agent Tests For Biologics, Rebecca Sheets
Vaccine Technology IV
No abstract provided.
Automation And Multiplexing Of Immunoassays: Improving Precision And Throughput, Ilia Tikhonov
Automation And Multiplexing Of Immunoassays: Improving Precision And Throughput, Ilia Tikhonov
Vaccine Technology IV
No abstract provided.
Microbial Fermentation: New Tools To Speed-Up Vaccine Antigen Development And Increase Process Knowledge, Catherine Jourdat
Microbial Fermentation: New Tools To Speed-Up Vaccine Antigen Development And Increase Process Knowledge, Catherine Jourdat
Vaccine Technology IV
No abstract provided.
Building Pandemic Preparedness Through A Sustainable Enterprise For Influenza Vaccines, Robert Huebner
Building Pandemic Preparedness Through A Sustainable Enterprise For Influenza Vaccines, Robert Huebner
Vaccine Technology IV
No abstract provided.
High Cell Density Cultivations For Influenza Virus Production Using Suspension Cells, Y. Genzel, T. Vogel, J. Buck, I. Behrendt, G. Schiedner, I. Jordan, U. Reichl
High Cell Density Cultivations For Influenza Virus Production Using Suspension Cells, Y. Genzel, T. Vogel, J. Buck, I. Behrendt, G. Schiedner, I. Jordan, U. Reichl
Vaccine Technology IV
No abstract provided.
Rmce-Based Sf9 Cell Factory For Production Of Multi-Meric Vlps, Ana Teixera
Rmce-Based Sf9 Cell Factory For Production Of Multi-Meric Vlps, Ana Teixera
Vaccine Technology IV
No abstract provided.
Bacterial Expression Of A Vlp Sub-Unit For Rapid And Cheap Influenza Vaccination, Anton Middelberg
Bacterial Expression Of A Vlp Sub-Unit For Rapid And Cheap Influenza Vaccination, Anton Middelberg
Vaccine Technology IV
No abstract provided.
Developing A Suite Of Analytics To Support Process Development For The Manufacture Of Polysaccharides, Aaron Noyes, Ranga Godavarti, Nigel Titchener-Hooker, Jonathan Coffman, Tarit Mukhopadhyay
Developing A Suite Of Analytics To Support Process Development For The Manufacture Of Polysaccharides, Aaron Noyes, Ranga Godavarti, Nigel Titchener-Hooker, Jonathan Coffman, Tarit Mukhopadhyay
Vaccine Technology IV
No abstract provided.
Cervical Cancer Immunotherapy: Induction Of Hpv Specific Ctls In Human Volunteers After Vgx-3100 Immunization, Niranjan Sardesai
Cervical Cancer Immunotherapy: Induction Of Hpv Specific Ctls In Human Volunteers After Vgx-3100 Immunization, Niranjan Sardesai
Vaccine Technology IV
No abstract provided.
A Protein-Free Process And Product Protection System, Stephen Ward
A Protein-Free Process And Product Protection System, Stephen Ward
Vaccine Technology IV
No abstract provided.
Functional Genomics As A Tool To Define A Molecular Signature Of Effective Vaccination Against Foot And Mouth Disease Virus, Jose Chabalgoity
Functional Genomics As A Tool To Define A Molecular Signature Of Effective Vaccination Against Foot And Mouth Disease Virus, Jose Chabalgoity
Vaccine Technology IV
No abstract provided.
Oncolytic Viruses As Cancer Therapies, Stephen Rusell
Oncolytic Viruses As Cancer Therapies, Stephen Rusell
Vaccine Technology IV
No abstract provided.
Chimpanzee Ad Vector Technology Platform For Prophylactic And Therapeutic Genetic Vaccine Applications, Stefano Colloca
Chimpanzee Ad Vector Technology Platform For Prophylactic And Therapeutic Genetic Vaccine Applications, Stefano Colloca
Vaccine Technology IV
No abstract provided.
Challenges In Optimizing Formulations For Multi- Antigen Vaccines, Lakshmi Khandke
Challenges In Optimizing Formulations For Multi- Antigen Vaccines, Lakshmi Khandke
Vaccine Technology IV
No abstract provided.
A New Successful Vaccine Against Babesiosis: Any Use For Malaria?, Thep Schetters
A New Successful Vaccine Against Babesiosis: Any Use For Malaria?, Thep Schetters
Vaccine Technology IV
No abstract provided.
The Cmc Challenges In Developing An Oncolytic Immunotherapy, Colin Love
The Cmc Challenges In Developing An Oncolytic Immunotherapy, Colin Love
Vaccine Technology IV
No abstract provided.
High Throughput Formulation Design For A Stable Lyophilized Virus-Like Particle Vaccine Against Group A Streptococcu, Yap Chuan
Vaccine Technology IV
No abstract provided.
Process Development For A Peptide Conjugated Qbetavirus Like Particle (Vlp) Vaccine, Jennifer Thorn
Process Development For A Peptide Conjugated Qbetavirus Like Particle (Vlp) Vaccine, Jennifer Thorn
Vaccine Technology IV
No abstract provided.
Formulation And Stability Of A Chikungunya Virus-Like Particle (Chikv Vlp) Based Vaccine, Rhicard Schwartz
Formulation And Stability Of A Chikungunya Virus-Like Particle (Chikv Vlp) Based Vaccine, Rhicard Schwartz
Vaccine Technology IV
No abstract provided.
Rift Valley Fever: Next Generation Vaccines For An Old Foe, Brian Bird
Rift Valley Fever: Next Generation Vaccines For An Old Foe, Brian Bird
Vaccine Technology IV
No abstract provided.
Leishmaniasis Vaccine Development: Animals As Models And Patients, Steven Reid
Leishmaniasis Vaccine Development: Animals As Models And Patients, Steven Reid
Vaccine Technology IV
No abstract provided.
Conference Program, Engineering Conferences International
Conference Program, Engineering Conferences International
Vaccine Technology IV
No abstract provided.
Tolerogenic Vaccination Exploiting Apoptotic Mechanisms Via Erythrocyte-To- Hepatic/Splenic Targeting, Jeffrey Hubbell
Tolerogenic Vaccination Exploiting Apoptotic Mechanisms Via Erythrocyte-To- Hepatic/Splenic Targeting, Jeffrey Hubbell
Vaccine Technology IV
No abstract provided.
Bringing Vaccine Manufacturing Capabilities To The Developing World, George Robertson
Bringing Vaccine Manufacturing Capabilities To The Developing World, George Robertson
Vaccine Technology IV
No abstract provided.
Rabies Virus-Like Particles Expressed In Hek293 Cells, Diego Fontana, Ricardo Kratje, Marina Etcheverrigaray, Claudio Prieto
Rabies Virus-Like Particles Expressed In Hek293 Cells, Diego Fontana, Ricardo Kratje, Marina Etcheverrigaray, Claudio Prieto
Vaccine Technology IV
No abstract provided.
Expectation Of China's Contribution To World Vaccine Development And Supplies: Status, Strategy And International Approach, Li Shi
Vaccine Technology IV
No abstract provided.
Process Understanding Approach For A Late-Stage Recombinant Protein Vaccine Produced In Saccharomyces Cerevisiae, Jose Manuel Otero, Brian Mickus, Amanda Schallop, Brian Doyle, Nedim Altaras
Process Understanding Approach For A Late-Stage Recombinant Protein Vaccine Produced In Saccharomyces Cerevisiae, Jose Manuel Otero, Brian Mickus, Amanda Schallop, Brian Doyle, Nedim Altaras
Vaccine Technology IV
No abstract provided.
Challenges In Development Of An Anti-Idiotypic Cancer Vaccine, Adolfo Castillo
Challenges In Development Of An Anti-Idiotypic Cancer Vaccine, Adolfo Castillo
Vaccine Technology IV
No abstract provided.
The Role Of Public-Private Partnerships In Advancing Vaccine Technologies And Improving Vaccine Effectiveness And Delivery For Developing Countries, Ray Cummings
Vaccine Technology IV
No abstract provided.